Risk-Set Matching to Assess the Impact of Hospital-Acquired Bloodstream Infections.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 18 07 2018
accepted: 05 11 2018
pubmed: 27 11 2018
medline: 19 11 2019
entrez: 27 11 2018
Statut: ppublish

Résumé

Hospital-acquired bloodstream infections have a definite impact on patient encounters and cause increased length of stay, costs, and mortality. However, methods for estimating these effects are potentially biased, especially if the time of infection is not incorporated into the estimation strategy. We focused on matching patient encounters in which a hospital-acquired infection occurred to comparable encounters in which an infection did not occur. This matching strategy is susceptible to a selection bias because inpatients that stay longer in the hospital are more likely to acquire an infection and thus also are more likely to have longer and more costly stays. Instead, we have proposed risk-set matching, which matches infected encounters to similar encounters still at risk for infection at the corresponding time of infection. Matching on the one-dimensional propensity score can create comparable pairs for a large number of characteristics; an analogous propensity score is described for risk-set matching. We have presented dramatically different estimates using these 2 approaches with data from a pediatric cohort from the Premier Healthcare Database, United States, 2009-2016. The results suggest that estimates that did not incorporate time of infection exaggerated the impact of hospital-acquired infections with regard to attributed length of stay and costs.

Identifiants

pubmed: 30475949
pii: 5210259
doi: 10.1093/aje/kwy252
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

461-466

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

David Watson (D)

Children's Minnesota Research Institute, Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota.

Alicen B Spaulding (AB)

Children's Minnesota Research Institute, Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota.

Jill Dreyfus (J)

Premier Applied Sciences, Premier, Inc., Charlotte, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH